You have read all your free articles, to continue reading subscribe to read the rest of this content.
Glooko has raised a USD 30 million Series D round of funding. The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. The new proceeds will accelerate execution of Glooko’s commercial strAlready a subscriber Login You have…
Orion Corporation and the Finnish Red Cross Blood Service have concluded an agreement on research collaboration with the aim of developing chimeric antigen receptor (CAR) T-cell therapy. The Blood Service has experience in cell research, in the supply of cord blood and stem cell grafts classifiedAlready a subscriber Login You…
AstraZeneca and its partner Amgen have announced that the US Food and Drug Administration has granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma, without an eosinophilic phenotype, who are receiving inhaled corticosteroids/long-acting beta2-agonists with or withoAlready a subscriber Login You have read all your free articles, to…
Alvotech has announced that its ordinary shares and warrants will begin trading on the Nasdaq Stock Market LLC on Thursday, June 16, under the new ticker symbols “ALVO” and “ALVOW”, respectively. This follows the completion of the company’s business combination with Oaktree Acquisition Already a subscriber Login You have read…
